vs
KITE REALTY GROUP TRUST（KRG）与Ultragenyx Pharmaceutical Inc.（RARE）财务数据对比。点击上方公司名可切换其他公司
Ultragenyx Pharmaceutical Inc.的季度营收约是KITE REALTY GROUP TRUST的1.0倍（$207.3M vs $200.7M），KITE REALTY GROUP TRUST净利率更高（0.2% vs -62.0%，领先62.2%），Ultragenyx Pharmaceutical Inc.同比增速更快（25.9% vs -9.2%），过去两年Ultragenyx Pharmaceutical Inc.的营收复合增速更高（38.0% vs -2.8%）
Kite Realty Group Trust是一家总部位于美国的上市房地产投资信托，主要持有、运营及开发露天购物中心与混合用途物业，资产组合覆盖美国多个核心区域市场，租户包括全国连锁零售品牌、本地独立商户及餐饮娱乐运营商，服务当地社区消费需求。
Ultragenyx Pharmaceutical Inc.是一家总部位于美国的生物制药企业，专注于研发罕见病和超罕见遗传病的创新治疗方案，这类疾病目前大多无获批疗法，存在大量未被满足的临床需求。公司覆盖生物制剂、小分子药物、基因疗法、反义寡核苷酸及mRNA等多种药物技术平台，研发管线涵盖骨骼、内分泌、代谢、肌肉及中枢神经系统疾病领域。
KRG vs RARE — 直观对比
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $200.7M | $207.3M |
| 净利润 | $330.0K | $-128.6M |
| 毛利率 | — | — |
| 营业利润率 | — | -54.7% |
| 净利率 | 0.2% | -62.0% |
| 营收同比 | -9.2% | 25.9% |
| 净利润同比 | -51.6% | 3.5% |
| 每股收益（稀释后） | $0.06 | $-1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q1 26 | $200.7M | — | ||
| Q4 25 | $204.2M | $207.3M | ||
| Q3 25 | $205.1M | $159.9M | ||
| Q2 25 | $213.4M | $166.5M | ||
| Q1 25 | $221.8M | $139.3M | ||
| Q4 24 | $214.7M | $164.6M | ||
| Q3 24 | $207.3M | $139.5M | ||
| Q2 24 | $212.4M | $147.0M |
| Q1 26 | $330.0K | — | ||
| Q4 25 | $180.8M | $-128.6M | ||
| Q3 25 | $-16.2M | $-180.4M | ||
| Q2 25 | $110.3M | $-115.0M | ||
| Q1 25 | $23.7M | $-151.1M | ||
| Q4 24 | $21.8M | $-133.2M | ||
| Q3 24 | $16.7M | $-133.5M | ||
| Q2 24 | $-48.6M | $-131.6M |
| Q1 26 | — | — | ||
| Q4 25 | — | -54.7% | ||
| Q3 25 | — | -106.9% | ||
| Q2 25 | — | -64.8% | ||
| Q1 25 | 24.2% | -102.6% | ||
| Q4 24 | 23.0% | -74.3% | ||
| Q3 24 | 21.7% | -94.6% | ||
| Q2 24 | -10.5% | -79.1% |
| Q1 26 | 0.2% | — | ||
| Q4 25 | 88.6% | -62.0% | ||
| Q3 25 | -7.9% | -112.8% | ||
| Q2 25 | 51.7% | -69.0% | ||
| Q1 25 | 10.7% | -108.5% | ||
| Q4 24 | 10.2% | -80.9% | ||
| Q3 24 | 8.1% | -95.7% | ||
| Q2 24 | -22.9% | -89.5% |
| Q1 26 | $0.06 | — | ||
| Q4 25 | $0.83 | $-1.28 | ||
| Q3 25 | $-0.07 | $-1.81 | ||
| Q2 25 | $0.50 | $-1.17 | ||
| Q1 25 | $0.11 | $-1.57 | ||
| Q4 24 | $0.10 | $-1.34 | ||
| Q3 24 | $0.08 | $-1.40 | ||
| Q2 24 | $-0.22 | $-1.52 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $32.5M | $421.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $2.9B | $-80.0M |
| 总资产 | $6.4B | $1.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q1 26 | $32.5M | — | ||
| Q4 25 | $36.8M | $421.0M | ||
| Q3 25 | $68.7M | $202.5M | ||
| Q2 25 | $182.0M | $176.3M | ||
| Q1 25 | $49.1M | $127.1M | ||
| Q4 24 | $478.1M | $174.0M | ||
| Q3 24 | $467.5M | $150.6M | ||
| Q2 24 | $273.8M | $480.7M |
| Q1 26 | — | — | ||
| Q4 25 | $3.0B | — | ||
| Q3 25 | $2.9B | — | ||
| Q2 25 | $3.0B | — | ||
| Q1 25 | $2.9B | — | ||
| Q4 24 | $3.2B | — | ||
| Q3 24 | $3.2B | — | ||
| Q2 24 | $3.0B | — |
| Q1 26 | $2.9B | — | ||
| Q4 25 | $3.1B | $-80.0M | ||
| Q3 25 | $3.2B | $9.2M | ||
| Q2 25 | $3.3B | $151.3M | ||
| Q1 25 | $3.3B | $144.2M | ||
| Q4 24 | $3.3B | $255.0M | ||
| Q3 24 | $3.3B | $346.8M | ||
| Q2 24 | $3.4B | $432.4M |
| Q1 26 | $6.4B | — | ||
| Q4 25 | $6.7B | $1.5B | ||
| Q3 25 | $6.6B | $1.2B | ||
| Q2 25 | $6.9B | $1.3B | ||
| Q1 25 | $6.7B | $1.3B | ||
| Q4 24 | $7.1B | $1.5B | ||
| Q3 24 | $7.1B | $1.5B | ||
| Q2 24 | $7.0B | $1.6B |
| Q1 26 | — | — | ||
| Q4 25 | 0.98× | — | ||
| Q3 25 | 0.93× | — | ||
| Q2 25 | 0.91× | — | ||
| Q1 25 | 0.89× | — | ||
| Q4 24 | 0.97× | — | ||
| Q3 24 | 0.97× | — | ||
| Q2 24 | 0.88× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $-99.8M |
| 自由现金流经营现金流 - 资本支出 | — | $-100.8M |
| 自由现金流率自由现金流/营收 | — | -48.6% |
| 资本支出强度资本支出/营收 | 3.3% | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-472.0M |
8季度趋势，按日历期对齐
| Q1 26 | — | — | ||
| Q4 25 | $106.6M | $-99.8M | ||
| Q3 25 | $116.2M | $-91.4M | ||
| Q2 25 | $132.8M | $-108.3M | ||
| Q1 25 | $74.1M | $-166.5M | ||
| Q4 24 | $111.0M | $-79.3M | ||
| Q3 24 | $112.4M | $-67.0M | ||
| Q2 24 | $142.1M | $-77.0M |
| Q1 26 | — | — | ||
| Q4 25 | — | $-100.8M | ||
| Q3 25 | — | $-92.7M | ||
| Q2 25 | — | $-110.7M | ||
| Q1 25 | — | $-167.8M | ||
| Q4 24 | — | $-79.5M | ||
| Q3 24 | — | $-68.6M | ||
| Q2 24 | — | $-79.0M |
| Q1 26 | — | — | ||
| Q4 25 | — | -48.6% | ||
| Q3 25 | — | -58.0% | ||
| Q2 25 | — | -66.5% | ||
| Q1 25 | — | -120.5% | ||
| Q4 24 | — | -48.3% | ||
| Q3 24 | — | -49.2% | ||
| Q2 24 | — | -53.7% |
| Q1 26 | 3.3% | — | ||
| Q4 25 | — | 0.5% | ||
| Q3 25 | — | 0.8% | ||
| Q2 25 | — | 1.5% | ||
| Q1 25 | — | 1.0% | ||
| Q4 24 | — | 0.1% | ||
| Q3 24 | — | 1.2% | ||
| Q2 24 | — | 1.4% |
| Q1 26 | — | — | ||
| Q4 25 | 0.59× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 1.20× | — | ||
| Q1 25 | 3.12× | — | ||
| Q4 24 | 5.09× | — | ||
| Q3 24 | 6.72× | — | ||
| Q2 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
KRG
| Rental income | $198.0M | 99% |
| Fee income | $1.3M | 1% |
RARE
| Royalty | $105.6M | 51% |
| Products | $101.7M | 49% |
